After three months of CBD-rich extract therapy, children with severe autism showed reduced internalizing behaviors, and their caregivers reported significantly improved mental health.
Developmental pediatricians, autism researchers, caregivers exploring treatment options
What the researchers found
In a prospective study of 16 patients with severe autism treated with CBD-rich extract and 17 untreated controls with moderate autism, the CBD group showed significant reduction in maladaptive internalizing behaviors on the Vineland 3 scale (p=0.008) after three months. Caregivers of the CBD group also showed significant improvements in interpersonal sensitivity (p=0.038), global severity (p=0.025), and positive symptom distress (p=0.007) on the Brief Symptom Inventory.
Why it matters
Treatment options for behavioral symptoms of autism remain limited. The dual finding of patient improvement and caregiver mental health benefits suggests that effective ASD treatment creates a positive cascade for the entire family.
The numbers in context
16 CBD patients (severe ASD, ATEC 85.5), 17 controls (moderate ASD, ATEC 58.6); CBD group: reduced internalizing behavior (p=0.008); caregiver improvements: interpersonal sensitivity (p=0.038), global severity (p=0.025), symptom distress (p=0.007)
How the study worked
Prospective, non-randomized observational study comparing 16 ASD patients receiving CBD-rich extract to 17 untreated controls. Assessments at baseline and 3 months using ATEC, CARS, Vineland 3 (patients) and BSI (caregivers).
What this study cannot tell us
Non-randomized design with groups differing in baseline severity (severe vs moderate ASD). Very small sample size. No blinding. Three-month follow-up may be insufficient. Caregiver mental health improvements could reflect placebo effect or hope from trying a new treatment.
How to read the evidence
Preliminary: small, non-randomized, unblinded study with baseline group differences.
When this study was published
2025 publication
The bigger picture
CBD for autism is an active area of research with growing parental interest and limited clinical data. This study adds to a small body of evidence suggesting potential benefits, particularly for anxiety and behavioral symptoms.
Questions still open
- Would a randomized, blinded trial confirm these benefits?
- Which specific ASD behavioral domains respond best to CBD?
Read the original research
Cannabinoid treatment impacts adaptive behavior in autism patients and caregivers' mental health: A prospective real-life cohort study.
Progress in brain research, 296, 29-53
Citation
Guimarães, Kelly Álvares; Jorge, Letícia Perígolo; Resende, Ana Luiza de Oliveira; da Silva Junior, Estácio Amaro; Kummer, Arthur Melo E; da Silva Lessa Júnior, Wilson; de Oliveira, Guilherme Nogueira M. (2025). Cannabinoid treatment impacts adaptive behavior in autism patients and caregivers' mental health: A prospective real-life cohort study.. Progress in brain research, 296, 29-53. https://doi.org/10.1016/bs.pbr.2025.08.014
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk